Workflow
Ryder(R)
icon
Search documents
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
ACCESSWIRE Newsroom· 2025-01-17 14:25
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program ...
Documentary Sensation “The Blue Angels” Soars Back Into Select Imax(R) Theatres as a New Version Offered in Breathtaking New Imax 3D Presentations Across the Globe Starting January 17th
ACCESSWIRE Newsroom· 2025-01-16 14:00
Documentary Sensation “The Blue Angels” Soars Back Into Select Imax(R) Theatres as a New Version Offered in Breathtaking New Imax 3D Presentations Across the Globe Starting January 17th ...
Ryder System: The Ride That Keeps On Delivering
Seeking Alpha· 2025-01-09 19:33
Approximately two years ago, in early January 2023, I wrote my last article about Ryder System, Inc. (NYSE: R ). For those not familiar with the business, it operates in the fleet management solutions business. It provides full-service leasing andCrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, ...
Here's Why Investors Should Give Ryder System Stock a Miss Now
ZACKS· 2025-01-03 17:26
Ryder System (R) is facing significant freight market challenges. Escalating operating expenses are adversely affecting the company’s bottom line, making it an unattractive choice for investors’ portfolios.Let’s delve deeper.Ryder: Key Risks to WatchSouthward Earnings Estimate Revision:The Zacks Consensus Estimate for 2025 earnings has been revised 1.14% downward over the past 60 days. The unfavorable estimate revision indicates brokers’ lack of confidence in the stock.Dim Price Performance: The company’s p ...
Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
Newsfile· 2024-12-26 12:00
Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of Vyvanse® (Lisdexamfetamine Disylate) with strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg capsules. The product is indicated for the treatment of attention deficit hyperactivity disorder (ADHD). This product is marketed ...
Edge Total Intelligence Recognized in the 2024 Gartner(R) Market Guide for Digital Twin of an Organization Platforms
Newsfile· 2024-12-12 08:01
Core Insights - Edge Total Intelligence Inc. has been recognized as a Representative Vendor in the 2024 Gartner Market Guide for Digital Twin of an Organization Platforms, highlighting its focus on operational excellence and various use cases including manufacturing/supply chain and business performance management [2][3]. Company Overview - Edge Total Intelligence provides real-time Digital Operations software that creates Digital Twins, enabling AI and other digital innovations [2]. - The company's platform, edgeCore™, integrates multiple software applications and data sources, enhancing situational awareness and accelerating action for global enterprises, service providers, and governments [9]. Industry Context - Gartner emphasizes that a digital twin of an organization aids in prioritizing, guiding, planning, monitoring, simulating, analyzing, and scaling complex initiatives, serving as a valuable resource for CIOs and technology innovation leaders [3]. - The recognition by Gartner is seen as a validation of edgeTI's capabilities, reinforcing the platform's value to prospective buyers [4]. Technological Capabilities - EdgeTI's platform allows data to be accessed directly where it resides, eliminating the need for additional databases or data warehouses, which accelerates time to value and reduces development costs [6]. - The platform's extensive data mesh and data fabric capabilities utilize in-memory storage, enabling real-time operational control and optimization across various industries [5][6].
GMG's THERMAL-XR(R) Demonstrates Potential for Electronics Heat Sink Miniaturization and Efficiency
Newsfile· 2024-12-11 13:15
Core Viewpoint - Graphene Manufacturing Group Ltd. (GMG) is advancing the commercialization of its THERMAL-XR® product, which enhances heat sink efficiency in electronics, enabling significant size reduction while maintaining thermal performance [1][7]. Customer Engagement Update - GMG is actively testing THERMAL-XR® with various companies across multiple industries, particularly for use in heat sinks for electronics [2]. Heat Sink Miniaturization - Third-party modeling indicates that applying THERMAL-XR® can reduce heat sink size by up to 39% while maintaining equivalent thermal performance, leading to potential savings in weight and material costs [3][6]. - A heat sink coated with THERMAL-XR® reaches a maximum temperature of 62 degrees Celsius, which is 23% lower than the 80 degrees Celsius maximum of an uncoated heat sink of the same size [3][4]. Market Potential - Global PCB production is projected to reach 530 million square meters annually by 2030, with an expected 5.2 billion units requiring heat sinks for cooling [6]. - If 0.1% of these applications utilize THERMAL-XR®, approximately 26.5 million liters of the coating could be used annually by 2030 [6]. Company Objectives - GMG's critical business objectives include producing graphene, building revenue from energy savings products, developing next-generation batteries, and enhancing supply chain and project execution capabilities [11][13]. Product Overview - THERMAL-XR® is a unique coating system that improves thermal heat transfer on heat exchange surfaces, leveraging the properties of GMG Graphene to enhance efficiency and potentially reduce power consumption [8][9].
Neos S&P 500(R) High Income ETF Harnesses the Power of Options
MarketBeat· 2024-12-11 11:55
Neos S&P 500(R) High Income ETF BATS: SPYI is an interesting play on the S&P 500 benchmarked to the CBOE’s S&P 500 Buy-Write index. The Buy-Write index tracks potential returns from an S&P 500-oriented covered call strategy, which is the SPYI’s primary focus. It is an actively managed fund utilizing proprietary techniques to pinpoint and profit from options activity, including long and short positions. Because the strategy is buy-focused, the fund is also positioned to increase in value in rising markets, a ...
First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel)
Newsfile· 2024-12-02 21:00
First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel)Dosing marks a milestone for first engineered cell therapy approved in the U.S. for a solid tumor cancer, synovial sarcomaDecember 02, 2024 4:00 PM EST | Source: Adaptimmune Therapeutics PLCPhiladelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - December 2, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor cancers with cell therapy, today ...
Here's Why Investors Should Retain Ryder Stock Right Now
ZACKS· 2024-11-27 15:40
Ryder’s (R) top line is bolstered by its recent acquisitions of Cardinal and IFS, boosting the company’s performance. The shareholder-friendly approach is encouraging. However, R is grappling with weak liquidity and escalated operating expenses.Factors Favoring RRyder's long-standing commitment to sustainability through initiatives like fleet upgrades, reducing truck idling, and improving route efficiency is commendable. A SmartWay partner since 2006, Ryder has earned the Excellence Award six times, demonst ...